Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

80.93 -1.46 (-1.77%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,734,579
Open 82.55
Bid (Size) 80.70 (1)
Ask (Size) 81.28 (4)
Prev. Close 82.39
Today's Range 80.70 - 82.60
52wk Range 73.31 - 129.93
Shares Outstanding 2,531,374,696
Dividend Yield 4.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report
Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies . 
Via Benzinga
Topics Government
2 S&P 500 Stocks with Promising Prospects and 1 to Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks

Performance

YTD
-18.4%
-18.4%
1 Month
+2.5%
+2.5%
3 Month
-0.3%
-0.3%
6 Month
-18.8%
-18.8%
1 Year
-35.7%
-35.7%

More News

Read More
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
Via Benzinga
What's going on in today's session: S&P500 gap up and gap down stocks
Via Chartmill
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Merck's Hypertension Drug On FDA Fast Track For Label Expansion
Via Benzinga
FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial
From Merck & Co., Inc.
Via Business Wire
MERCK & CO. INC. (NYSE:MRK) – A Strong Value Candidate in Healthcare
Via Chartmill
Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3%
Via Benzinga
Topics Stocks
Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?
Via Benzinga
Topics Stocks
Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29
From Merck & Co., Inc.
Via Business Wire
HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best?
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
Via Investor's Business Daily
Peering Into Merck & Co's Recent Short Interest
Via Benzinga
1 Profitable Stock to Consider Right Now and 2 to Think Twice About
Via StockStory
3 Absurdly Cheap Stocks Ready for a Breakout
Via The Motley Fool
RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants
Via Benzinga
CDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound Alarm
Via Stocktwits
5 Biotech Stocks with Highly Anticipated Pending Results
Via Stocktwits
Topics Intellectual Property
Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise
Via Benzinga
ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
From Merck & Co., Inc.
Via Business Wire
2 Stocks Too Cheap to Ignore at These Prices
Via The Motley Fool
Topics Artificial Intelligence Lawsuit
RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group
Via Benzinga
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention
From Merck & Co., Inc.
Via Business Wire

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 80.93
When was Merck & Co last traded?
The last trade of Merck & Co was at 07/03/25 05:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 204.86B
How many shares of Merck & Co are outstanding?
Merck & Co has 205B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.